Literature DB >> 24978373

Phenotypic characteristics of diabetic kidney involvement.

Roland C Blantz1.   

Abstract

Understanding phenotypic characteristics of the diabetic kidney is important for the development of therapies to prevent progression of diabetic nephropathy. In addition to glomerular hyperfiltration and kidney growth, major metabolic abnormalities characterize the diabetic kidney. Increased kidney oxygen consumption leads to cortical and medullary hypoxia in diabetes. Decreasing inspired oxygen to 10% reduces pO2, while oxygen consumption remains elevated, lactate increases, and redox potential decreases, but only in the diabetic kidney--a shift to Warburg metabolism.

Entities:  

Mesh:

Year:  2014        PMID: 24978373      PMCID: PMC4076684          DOI: 10.1038/ki.2013.552

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


During the past decade and a half, we have become aware of the large number of persons afflicted with chronic kidney disease.[1] Diabetes mellitus is the dominant cause of ESRD in the USA and therefore contributes greatly to the CKD population of over 20 million individuals in the USA.[1, 2] Slowing the rate of progression of CKD and diabetic nephropathy is of obvious greater importance. In order to determine effective therapies, we need to define better the phenotypic characteristics of CKD and diabetic kidney involvement. This information has been rather slow in coming, with developments primarily deriving from experimental animal models of CKD and diabetes. In 2000, Leon Fine and colleagues suggested that chronic kidney hypoxia might be a phenotypic characteristic of models of kidneys with decreased surviving nephrons.[3] During the past decade, several studies of experimental animal models of CKD and the diabetic kidney have verified the earlier prediction that kidney hypoxia does persist in both CKD[4-6] and early diabetic kidney.[7] Why should hypoxia develop as a primary characteristic or adaptation to chronic kidney disease and the diabetic kidney? Early studies in the subtotal nephrectomy model demonstrated that peritubular capillary rarefaction does occur [5] raising the question as to whether the hypoxia was primarily ischemic in origin However, this seems less likely given the anatomic arrangement of arterial and venous vessels in the kidney. Studies earlier by Schurek provided evidence for a countercurrent oxygen exchange system within the kidney whereby the cortical pO2 was maintained at relatively low levels of 40–45 mmHg in spite of wide variations in inspired oxygen and arterial oxygen tension from below those values to as high as 500 mmHg.[8] Therefore, the kidney, of all organs, should be able to defend itself from wide variations in inspired oxygen and arterial oxygen tension. Later studies in CKD models and in the early diabetic kidney observed that the lower cortical and medullary oxygen tensions observed were associated with increased oxygen utilization rather than a consequence of decreased oxygen delivery and blood flow. [4,6,7] In general, models of CKD and diabetic kidney involvement have demonstrated elevated levels of nephron filtration rate and reabsorption, but also increased levels of nephron blood flow, making classical “ischemia” unlikely and not a cause for cortical and medullary hypoxia. Greater kidney oxygen consumption could have been attributed to increased tubular reabsorption of NaCl per nephron since both CKD models and early diabetes are associated with glomerular hyperfiltration per nephron unit. However, when kidney oxygen consumption is factored by the quantity of NaCl reabsorbed, oxygen consumption remained increased and progressively over time in the case of the subtotal nephrectomy model of CKD. [4,6,7,9] In the diabetic kidney, primary hyperabsorption by the proximal tubule does not fully explain the increase in kidney oxygen consumption since oxygen consumption factored by NaCl reabsorption is still increased.[7] Several laboratories have largely agreed that metabolic efficiency in CKD and the diabetic kidney are markedly reduced and overall oxygen consumption increased.[4,6,7,9] However, there is no universal agreement as to the causes of the reduction in metabolic efficiency and increased oxygen costs. This reduction in metabolic efficiency correlates well with the development of kidney fibrosis and declines in kidney hemodynamics.[3,6,9] In CKD and diabetes, gluconeogenesis may be increased and contribute to oxygen requirements because of increased ATP needs to synthesize glucose. However, other etiologies have also been proposed and tested. Inhibition of angiotensin II activity and the restoration of NOS activity normalize oxygen consumption and the prevention of reactive oxygen species also plays a corrective role in both CKD and diabetic kidneys.[4,6] Several other treatments including amplification of hypoxia inducible factor and restoration of the observed reduction in AMPK activity in CKD (using metformin and AICAR) and diabetes have also normalized oxygen consumption and renal hemodynamics.[6,9] It is of major interest that these divergent treatments share not only normalization of oxygen efficiency and renal hemodynamics but also prevent the later development of kidney fibrosis and deterioration of kidney function. [6,9] The mechanism linking increased oxygen consumption, the consequent hypoxia, and the development of kidney fibrosis and declines in kidney function remains largely undetermined. Clearly, the finding of kidney hypoxia is related to increased oxygen utilization and is not due to deficiency in oxygen delivery. The current study has utilized a combination of microelectrode measurements, BOLD MRI and metabolic assessments to evaluate the role of oxygen sensitivity early in the diabetic kidney.[10] Microelectrode and MRI assessments verify previous observations of significant cortical and medullary hypoxia in early diabetic kidney, presumably related to increased oxygen consumption.[7] When exposed to 10% oxygen, cortical and medullary pO2 declined in both control and diabetic kidneys but oxygen tensions were approximately 10 mmHg lower in the diabetic kidney cortex than in control kidneys at normal and reduced inspired pO2 values. Lactate and pyruvate levels and oxidative metabolism overall were not changed in the control kidneys exposed to 10% oxygen tensions. The major site of oxygen consumption in normal kidneys is the proximal tubule, and the metabolic activity is solely oxidative since glycolytic activity is essentially absent in normal proximal tubules. However, when the diabetic kidneys were exposed to 10% inspired oxygen, the cortical pO2 was reduced to approximately 25 mmHg relative to 35 mmHg in control kidneys. This produced greater changes in lactate and pyruvate and the lactate/pyruvate ratio increased markedly in the diabetic kidney. Total oxidative metabolism was not changed however, suggesting that this finding was not simply the result of increased glycolysis since the other indicator of redox potential, NAD+/NADH, was also reduced in parallel with the increase in lactate/pyruvate ratio. Implicit to the results of this study is that the greater reduction in kidney pO2 as a consequence of reductions in inspired oxygen in the diabetic kidney forms the basis of the major differences in lactate and pyruvate generation and increased LDHA activity, while oxidative activity was largely unchanged. The greater redox potential and lactate response in the diabetic kidney implies a state of greater mitochondrial stress. Further studies must now differentiate whether these effects are due entirely to the lower cortical and medullary pO2 values or processes specific to the adapted diabetic mitochondria. Would further reductions in inspired pO2 in control kidneys sufficient to reduce oxygen levels to approximately 25 mmHg comparable to diabetic kidneys also lead to major increases in lactate levels, LDHA activity and major reductions in NAD+/NADH ratios? This issue is critical to the conclusion that progression of diabetic nephropathy could be more severe at higher altitude exposure as a consequence of further reductions in tissue pO2. Since oxidative metabolism was not reduced in the diabetic kidney, this may represent Warburg metabolism or other mitochondrial stresses reducing the redox potential of the diabetic kidney with lower inspired oxygen breathing. How much hypoxia and what altitude and inspired oxygen levels are required to trigger this Warburg process? After such determinations, then we may be able to determine why these processes contribute to greater kidney fibrosis. These observations remain correlative and the signal mediating the marked alterations in NAD+/NADH ratio and lactate generation with hypoxia remains to be determined.
  9 in total

1.  Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex.

Authors:  H J Schurek; U Jost; H Baumgärtl; H Bertram; U Heckmann
Journal:  Am J Physiol       Date:  1990-12

Review 2.  Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia.

Authors:  L G Fine; D Bandyopadhay; J T Norman
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

3.  Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II.

Authors:  Aihua Deng; Cynthia M Miracle; Jorge M Suarez; Mark Lortie; Joseph Satriano; Scott C Thomson; Karen A Munger; Roland C Blantz
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

Review 4.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

5.  Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.

Authors:  Joseph Satriano; Kumar Sharma; Roland C Blantz; Aihua Deng
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

6.  The chronic kidney disease initiative.

Authors:  Thomas F Parker; Roland Blantz; Thomas Hostetter; Jonathan Himmelfarb; Alan Kliger; Michael Lazarus; Allen R Nissenson; Brian Pereira; James Weiss
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

7.  Evidence of tubular hypoxia in the early phase in the remnant kidney model.

Authors:  Krissanapong Manotham; Tetsuhiro Tanaka; Makiko Matsumoto; Takamoto Ohse; Toshio Miyata; Reiko Inagi; Kiyoshi Kurokawa; Toshiro Fujita; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

8.  Increased renal metabolism in diabetes. Mechanism and functional implications.

Authors:  A Körner; A C Eklöf; G Celsi; A Aperia
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

9.  Oxygen consumption and oxidant stress in surviving nephrons.

Authors:  K A Nath; A J Croatt; T H Hostetter
Journal:  Am J Physiol       Date:  1990-05
  9 in total
  10 in total

1.  Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin; Keizo Kanasaki; Daisuke Koya
Journal:  Br J Pharmacol       Date:  2020-06-22       Impact factor: 8.739

2.  Dapagliflozin Attenuates Contrast-induced Acute Kidney Injury by Regulating the HIF-1α/HE4/NF-κB Pathway.

Authors:  Xu Huang; Xiaoxu Guo; Gaoliang Yan; Yang Zhang; Yuyu Yao; Yong Qiao; Dong Wang; Gecai Chen; Weiwei Zhang; Chengchun Tang; Feng Cao
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

3.  Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.

Authors:  Ryoichi Bessho; Yumi Takiyama; Takao Takiyama; Hiroya Kitsunai; Yasutaka Takeda; Hidemitsu Sakagami; Tsuguhito Ota
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

4.  The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation.

Authors:  Haijie Liu; Yuta Takagaki; Asako Kumagai; Keizo Kanasaki; Daisuke Koya
Journal:  J Diabetes Investig       Date:  2020-12-31       Impact factor: 4.232

5.  Diagnostic roles of urinary kidney microvesicles in diabetic nephropathy.

Authors:  Fang-Hao Cai; Wen-Yan Wu; Xu-Jie Zhou; Xiao-Juan Yu; Ji-Cheng Lv; Su-Xia Wang; Gang Liu; Li Yang
Journal:  Ann Transl Med       Date:  2020-11

Review 6.  Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease.

Authors:  Mengdi Wang; Yanyu Pang; Yifan Guo; Lei Tian; Yufei Liu; Cun Shen; Mengchao Liu; Yuan Meng; Zhen Cai; Yuefen Wang; Wenjing Zhao
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

7.  Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.

Authors:  Wei-Jian Ni; Li-Qin Tang; Hong Zhou; Hai-Hua Ding; Yuan-Ye Qiu
Journal:  J Cell Mol Med       Date:  2016-04-21       Impact factor: 5.310

8.  SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis.

Authors:  Swayam Prakash Srivastava; Jinpeng Li; Munehiro Kitada; Hiroki Fujita; Yuichiro Yamada; Julie E Goodwin; Keizo Kanasaki; Daisuke Koya
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

9.  New Insights into the Pathogenesis of Diabetic Nephropathy: Proximal Renal Tubules Are Primary Target of Oxidative Stress in Diabetic Kidney.

Authors:  Ryuma Haraguchi; Yukihiro Kohara; Kanako Matsubayashi; Riko Kitazawa; Sohei Kitazawa
Journal:  Acta Histochem Cytochem       Date:  2020-04-25       Impact factor: 1.938

Review 10.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.